CD74 and hereditary clear cell renal cell carcinoma: In a study of patients with various solid tumors (including renal cell carcinoma) who received combination anti-CTLA-4 and anti-PD-1 ICB treatment, a higher expression of CD74 autoantibodies measured in the serum before ICB therapy was correlated with the development of irAE pneumonitis [93].